Trial Profile
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil plus darunavir regimen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2016
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 19 Oct 2016 New trial record